
HISTORY OF PRESENT ILLNESS: This is a follow-up visit for the patient's chronic hypertension and hyperlipidemia. He has been taking lisinopril 20 mg daily and atorvastatin 40 mg daily for several years. He reports good compliance with his medications and has not experienced any side effects. He denies any symptoms of chest pain, shortness of breath, palpitations, or edema. He has no history of stroke or transient ischemic attack. He has not experienced any visual disturbances or changes in mental status.

PAST MEDICAL HISTORY: Hypertension, hyperlipidemia, and type 2 diabetes mellitus.

SOCIAL HISTORY: The patient is a retired construction worker and is currently living with his wife. He does not smoke or drink alcohol.

REVIEW OF SYSTEMS: The patient reports occasional headaches but denies any other symptoms. He has no history of gastrointestinal bleeding or kidney disease. He has not experienced any recent weight loss or gain.

PHYSICAL EXAMINATION: Blood pressure 134/82 mmHg, pulse 76 beats per minute. The patient appears comfortable and in no acute distress. Heart sounds regular with no murmurs or gallops. Lungs are clear to auscultation bilaterally. Abdomen is soft, non-tender, and non-distended. There is no hepatosplenomegaly or masses palpated. No peripheral edema noted. Neurological examination is unremarkable.

LABORATORY WORK: Fasting blood glucose 128 mg/dL, hemoglobin A1c 7.2%, total cholesterol 178 mg/dL, LDL cholesterol 108 mg/dL, HDL cholesterol 48 mg/dL, triglycerides 137 mg/dL. Serum creatinine and electrolytes are within normal limits.

IMPRESSION AND PLAN: The patient's hypertension and hyperlipidemia are well-controlled on his current medications. The patient's diabetes control needs improvement, with a hemoglobin A1c of 7.2%. The patient will be counseled on lifestyle modifications including diet and exercise. He will also be started on metformin 500 mg twice daily with titration to target hemoglobin A1c of less than 7%. The patient will follow up in 3 months for repeat labs and assessment of glycemic control.```
